Holen Sie sich die Stockscreener-App
0.3503
3.00%
0.0102
Handel nachbörslich:
.36
0.0097
+2.77%
Schlusskurs vom Vortag:
$0.3401
Offen:
$0.3301
24-Stunden-Volumen:
628.57K
Relative Volume:
0.60
Marktkapitalisierung:
$27.50M
Einnahmen:
$4.17M
Nettoeinkommen (Verlust:
$-27.71M
KGV:
-0.9468
EPS:
-0.37
Netto-Cashflow:
$-22.23M
1W Leistung:
-9.58%
1M Leistung:
-15.61%
6M Leistung:
-56.21%
1J Leistung:
-63.51%
1-Tages-Spanne:
$0.33
$0.3535
1-Wochen-Bereich:
$0.33
$0.385
52-Wochen-Spanne:
$0.292
$1.65
Clearside Biomedical Inc Stock (CLSD) Company Profile
Firmenname
Clearside Biomedical Inc
Sektor
Branche
Telefon
678-270-3631
Adresse
900 NORTH POINT PARKWAY, ALPHARETTA, GA
Vergleichen Sie CLSD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLSD
Clearside Biomedical Inc
|
0.3503 | 26.62M | 4.17M | -27.71M | -22.23M | -0.37 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-18 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2025-07-18 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-07-18 | Herabstufung | Stifel | Buy → Hold |
| 2024-08-21 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-06-25 | Eingeleitet | Oppenheimer | Outperform |
| 2021-12-15 | Fortgesetzt | Wedbush | Outperform |
| 2021-07-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-05-13 | Eingeleitet | ROTH Capital | Buy |
| 2019-08-09 | Herabstufung | Needham | Buy → Hold |
| 2018-11-05 | Herabstufung | Cowen | Outperform → Market Perform |
| 2018-11-05 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2018-11-05 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-06 | Bestätigt | Needham | Buy |
| 2017-05-25 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2017-02-24 | Eingeleitet | JP Morgan | Overweight |
| 2016-11-10 | Bestätigt | Needham | Buy |
| 2016-10-24 | Bestätigt | Stifel | Buy |
Alle ansehen
Clearside Biomedical Inc Aktie (CLSD) Neueste Nachrichten
Clearside Biomedical Approves Reverse Stock Split Proposal - TipRanks
What momentum shifts mean for Clearside Biomedical Inc.Earnings Risk Report & Fast Gain Stock Tips - Newser
Building trade automation scripts for Clearside Biomedical Inc.July 2025 Levels & Risk Managed Investment Signals - Newser
Understanding Clearside Biomedical Inc.’s price movement2025 Historical Comparison & Risk Controlled Stock Pick Alerts - Newser
Tick level data insight on Clearside Biomedical Inc. volatilityPrice Action & Stock Market Timing Techniques - Newser
Analyzing net buyer seller activity in Clearside Biomedical Inc.New Guidance & Real-Time Market Trend Scan - Newser
Can volume confirm reversal in Clearside Biomedical Inc.Dollar Strength & High Conviction Investment Ideas - Newser
Live market analysis of Clearside Biomedical Inc.2025 Key Highlights & Weekly Setup with ROI Potential - Newser
Clearside Biomedical Inc. stock prediction for this weekQuarterly Market Review & Fast Gain Stock Trading Tips - Newser
Using AI based signals to follow Clearside Biomedical Inc.Market Growth Summary & Weekly Top Gainers Trade List - Newser
Applying big data sentiment scoring on Clearside Biomedical Inc.Exit Point & High Win Rate Trade Alerts - Newser
Backtesting results for Clearside Biomedical Inc. trading strategies - Newser
Clearside Biomedical Inc. stock trend outlook and recovery pathJuly 2025 Weekly Recap & Capital Efficiency Focused Strategies - Newser
Is Clearside Biomedical Inc. stock reversal real or fakePortfolio Return Report & Detailed Earnings Play Alerts - Newser
Should I hold or sell Clearside Biomedical Inc. nowJuly 2025 Patterns & Real-Time Buy Signal Alerts - khodrobank.com
Can Clearside Biomedical Inc. generate free cash flowJuly 2025 Chart Watch & High Accuracy Trade Signal Alerts - khodrobank.com
Is Clearside Biomedical Inc.’s ROIC above industry average2025 Price Momentum & Smart Investment Allocation Insights - khodrobank.com
Should value investors consider Clearside Biomedical Inc.CPI Data & Breakout Confirmation Trade Signals - khodrobank.com
Does Clearside Biomedical Inc. outperform in volatile marketsJuly 2025 Snapshot & Real-Time Chart Breakout Alerts - khodrobank.com
Clearside Biomedical Receives Canadian Approval for XIPERE® to Treat Uveitic Macular Edema via Suprachoroidal Delivery - MSN
Clearside Biomedical Inc. stock outlook for YEARWeekly Trade Analysis & Consistent Income Trade Recommendations - Newser
Measuring Clearside Biomedical Inc.’s beta against major indices2025 Volume Leaders & High Conviction Investment Ideas - Newser
What institutions are buying Clearside Biomedical Inc. stock nowPortfolio Growth Summary & Smart Money Movement Tracker - Newser
Using portfolio simulators with Clearside Biomedical Inc. includedWeekly Trend Summary & Long-Term Capital Growth Ideas - Newser
Custom strategy builders for tracking Clearside Biomedical Inc.Quarterly Trade Review & High Accuracy Trade Alerts - Newser
Published on: 2025-08-30 21:12:57 - Newser
Is Clearside Biomedical Inc. affected by consumer sentimentQuarterly Risk Review & Real-Time Stock Price Movement Reports - theviewers.co.kr
Can Clearside Biomedical Inc. Regain Lost Ground This Quarter2025 Key Lessons & Fast Entry Momentum Alerts - beatles.ru
What are analysts’ price targets for Clearside Biomedical Inc.Market Performance Summary & Real-Time Chart Pattern Alerts - kpenews.com
Is Clearside Biomedical Inc. trending in predictive chart modelsEarnings Overview Report & Comprehensive Market Scan Insights - Newser
Sentiment Turns Positive on Clearside Biomedical Inc. — Reversal Ahead getLinesFromResByArray error: size == 0 - thegnnews.com
Clearside Biomedical Posts Q2 2025 Earnings Miss; Market Reaction Signals Investor Caution - AInvest
Intraday pattern recognizer results for Clearside Biomedical Inc.2025 Valuation Update & Safe Capital Growth Stock Tips - Newser
Combining machine learning predictions for Clearside Biomedical Inc.Weekly Trade Report & Weekly Breakout Watchlists - Newser
Finanzdaten der Clearside Biomedical Inc-Aktie (CLSD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Clearside Biomedical Inc-Aktie (CLSD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Chong Ngai Hang Victor | Chief Medical Officer |
Nov 01 '24 |
Buy |
1.00 |
36,500 |
36,500 |
100,000 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):